Supersapiens Launches Diabetes Platform in the US

09.01.2024

Supersapiens, backed by our Swiss Diabetes Venture Fund, launches cutting-edge Diabetes platform, empowering users to manage glucose levels. US free beta version invites feedback for continuous improvement.

Supersapiens, backed by our Swiss Diabetes Venture Fund, launches cutting-edge Diabetes platform, empowering users to manage glucose levels. US free beta version invites feedback for continuous improvement.

Similar Articles

04.11.2025

RAAAM Raises USD 17.5M Series A Led by NXP Semiconductors

03.09.2025

Voltiris Ranks 4th at the 2025 TOP 100 Swiss Startup Awards

20.08.2025

Luna Diabetes Closes Series A to Transform Nighttime Glucose Control

18.08.2025

evulpo closes CHF 8.8M Series A

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

Your cookie preferences have been saved.